Skip to main content

Advertisement

Table 4 Comparison of the drug use pattern of the 127,977 diabetic subjects between 2009 and 2013

From: Five-year change of clinical and complications profile of diabetic patients under primary care: a population-based longitudinal study on 127,977 diabetic patients

Type of therapy 2009 (%) 2013 (%)
Lifestyle modification only 15.7 10.2
Oral anti-diabetic drug only 83.7 86.3
Insulin only 0.2 0.5
Oral anti-diabetic drug + insulin 0.5 3.0
Anti-diabetic drugs
 Metformin 71.1 80.4
 Sulphonylurea 57.0 60.4
 Gliptin 0.0 1.2
 Insulin 0.6 3.5
 Others 0.1 0.1
Anti-hypertensive drugsa
 None 2.5 3.6
 ACEI or ARB 59.4 58.3
 β-blocker 39.2 35.5
 CCB 73.9 71.0
 Diuretic 11.8 10.7
 Other anti-hypertensive drugs 15.1 13.8
Lipid lowering drugs
 Statin 9.0 (15.8 %)b 55.0 (56.9 %)b
 Fibrate 4.6 2.5
Aspirin 8.8 (75.8 %)c 14.0 (75.7 %)c
  1. Others included Acarbose, Glucagon-like peptide-1 agonist, Meglitinides
  2. ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker
  3. aThe denominator was diabetic patients with hypertension (93,234 and 106,361 at 2009 and 2013, respectively)
  4. bThe bracket shows the proportion of diabetic patients with hyperlipidemia who are put on statin
  5. cThe bracket shows the proportion of diabetic patients with confirmed CVD who were put on aspirin